Valuation: Abbott Laboratories

Market Cap 181B 162B 150B 136B 256B 17,208B 260B 1,798B 707B 8,994B 681B 667B 28,751B P/E 2026 *
30.9x
P/E 2027 * 24x
Enterprise Value 205B 183B 170B 154B 289B 19,478B 294B 2,035B 800B 10,180B 771B 755B 32,543B EV / Sales 2026 *
4.09x
EV / Sales 2027 * 3.71x
Free-Float
86.16%
Yield 2026 *
2.45%
Yield 2027 * 2.61%
1 day-0.45%
1 week+2.45%
Current month+5.54%
1 month+1.29%
3 months+2.61%
6 months+8.66%
Current year-16.75%
1 week 100.63
Extreme 100.631
105.88
1 month 95.06
Extreme 95.06
105.88
Current year 81.97
Extreme 81.97
129.46
1 year 81.97
Extreme 81.97
132.02
3 years 81.97
Extreme 81.97
141.23
5 years 81.97
Extreme 81.97
142.6
10 years 37.38
Extreme 37.38
142.6
Manager TitleAgeSince
Chief Executive Officer 52 2020-03-30
Director of Finance/CFO 53 2023-08-31
Chief Investment Officer 51 -
Director TitleAgeSince
Director/Board Member 64 2011-12-08
Director/Board Member 67 2011-12-08
Director/Board Member 71 2017-02-15
Date Insider Type Main position Quantity % Market Cap. Importance
9/30/26 Free

Director

333 0.0000%
9/30/26 Free

Director

318 0.0000%
9/30/26 Free

Director

381 0.0000%
Change 5-day change 1-year change 3-year change Capi.($)
-0.47%+2.45%-19.46%+9.29% 181B
-1.70%+1.27%-2.94%+28.68% 116B
+1.86%+6.08%-21.36%+11.68% 113B
-1.52%+3.61%-51.56%-6.22% 79.83B
-0.30%+4.33%+3.59%+78.59% 65.06B
-0.27%+2.10%+15.54%+66.81% 54.35B
-0.09%+1.46%+0.34%-25.57% 52.23B
-0.26%+6.74%-13.08%+31.38% 44.15B
+0.18%+0.34%+25.99%+0.20% 32.47B
-0.33%+2.10%-8.95%-16.45% 32.12B
Average -0.32%+4.96%-7.19%+17.84% 77.07B
Weighted average by Cap. -0.33%+5.40%-12.10%+18.31%

Financials

2026 *2027 *
Net sales 50.2B 44.75B 41.45B 37.69B 70.72B 4,759B 71.88B 497B 196B 2,487B 188B 184B 7,952B 54.53B 48.6B 45.02B 40.94B 76.82B 5,170B 78.08B 540B 212B 2,702B 205B 200B 8,637B
Net income 6.16B 5.49B 5.09B 4.63B 8.68B 584B 8.82B 61.03B 24B 305B 23.12B 22.64B 976B 7.84B 6.99B 6.48B 5.89B 11.05B 744B 11.23B 77.68B 30.55B 389B 29.43B 28.81B 1,242B
Net Debt 23.94B 21.34B 19.77B 17.97B 33.73B 2,270B 34.28B 237B 93.23B 1,186B 89.82B 87.94B 3,792B 20.96B 18.68B 17.31B 15.73B 29.53B 1,987B 30.01B 208B 81.62B 1,038B 78.63B 76.98B 3,320B
Projected Income Statement - Annual - Abbott Laboratories
Logo Abbott Laboratories
Abbott Laboratories specializes in the research, development, manufacturing and marketing of pharmaceutical and medical products. Net sales break down by family of products as follows: - vascular devices (48.3%): endoprosthetic systems, dilation catheters, arterial closures, etc.; - diagnostic systems and instruments (20.2%); - nutrition products (19.1%): pediatric nutrition products, nutritional supplements, and dietetic products; - medicine (12.4%): anesthetics, antiviral products, antibiotics, inhibitors, anti-inflammatories, etc. Net sales are distributed geographically as follows: the United States (38.7%), Germany (6.2%), China (4.3%), India (4.2%), Switzerland (4.2%), Japan (3.3%), the United Kingdom (3%) and others (36.1%).
Employees
115,000
Date Price Change Volume
26-10-19 $104.03 -0.82% 5,183,926
26-10-16 $104.89 +0.20% 8,243,827
26-10-15 $104.68 +1.66% 12,747,613
26-10-14 $102.97 +0.35% 7,286,701
26-10-13 $102.61 +0.78% 9,864,564
Trader
Investor
Global
Quality
ESG MSCI
BBB
MarketScreener Ratings - Abbott Laboratories
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
104.89USD
Average target price
120.72USD
Spread / Average Target
+15.09%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Abbott Laboratories